Ibudilast for prevention of oxaliplatin-induced acute neurotoxicity: a pilot study assessing preliminary efficacy, tolerability and pharmacokinetic interactions in patients with metastatic gastrointestinal cancer

- Teng, Christina, Reuter, Stephanie E., Blinman, Prunella L., Dhillon, Haryana M., Galettis, Peter, Proschogo, Nicholas, McLachlan, Andrew J., Vardy, Janette L.

Gender differences in doxorubicin pharmacology for subjects with chemosensitive cancers of young adulthood

- Liu, Z., Martin, J., Orme, L., Seddon, B., Desai, J., Nicholls, W., Thomson, D., Porter, D., McCowage, G., Underhill, C., Cranswick, N., Michael, M., Zacharin, M., Herschtal, A., Sivasuthan, J., Thomas, D. M.

Monte Carlo simulations of the clinical benefits from therapeutic drug monitoring of sunitinib in patients with gastrointestinal stromal tumours

- Goulooze, Sebastiaan C., Galettis, Peter, Boddy, Alan V., Martin, Jennifer H.

Risk and outcomes of chemotherapy-induced diarrhea (CID) among patients with colorectal cancer receiving multi-cycle chemotherapy

- Keefe, Dorothy M., Elting, Linda S., Nguyen, Hoang T., Grunberg, Steven M., Aprile, Giuseppe, Bonaventura, Antony, Selva-Nayagam, Sudarsha, Barsevick, Andrea, Koczwara, Bogda, Sonis, Stephen T.

Fixed-dose-rate gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas

- Goldstein, David, Gainford, M Corona, Miller, Danielle, Shannon, Jenny, Brown, Chris, Tebbutt, Niall, Ackland, Stephen P., van Hazel, Guy, Jefford, Michael, Abdi, Ehtesham, Selva-Nayagam, Sid, Gebski, Val

Pyridoxine to protect from oxaliplatin-induced neurotoxicity without compromising antitumour effect

- Garg, Madhu B., Ackland, Stephen P.

Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition

- Sakoff, Jennette A., Howitt, Ian J., Ackland, Stephen P., McCluskey, Adam